| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 139,049 | 136,110 | 149,745 | 180,331 | | Cost of Revenue | 102,890 | 100,212 | 116,993 | 174,858 | | | Gross Profit | 36,159 | 35,898 | 32,752 | 5,473 | | | Operating Expenses | | Research Development | 14,533 | 14,593 | 15,147 | 18,745 | | Selling General and Administrative | 19,220 | 21,606 | 21,840 | 23,222 | | Non Recurring | 1,076 | 151 | 1,498 | 328,229 | | Others | (534) | 207 | 327 | 1,662 | | | | Total Operating Expenses | 34,295 | 36,557 | 38,812 | 371,858 | | | | Operating Income or Loss | 1,864 | (659) | (6,060) | (366,385) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (6,506) | 12,026 | 5,430 | 47,801 | | Earnings Before Interest And Taxes | (4,642) | 11,367 | (630) | (318,584) | | Interest Expense | (5,737) | 5,737 |
-
| 2,861 | | Income Before Tax | 1,095 | 5,630 | (630) | (321,445) | | Income Tax Expense | 803 | (718) | 1,470 | 947 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 292 | 6,348 | (2,100) | (322,392) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 292 | 6,348 | (2,100) | (322,392) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $292 | $6,348 | ($2,100) | ($322,392) |
|
1.52% Nasdaq 0.00%
Income Statement
